Full Text View
Tabular View
No Study Results Posted
Related Studies
Multicenter, Randomized, Controlled Study of the Effect of Lotemax on Initiation of Dry Eye Treatment With Restasis
This study is currently recruiting participants.
Study NCT00407043   Information provided by Ophthalmic Consultants of Long Island
First Received: November 30, 2006   Last Updated: December 4, 2006   History of Changes
Related Studies can be found by searching for the Conditions, Interventions, and Sponsors found in this study:
Conditions listed in this trial
Dry Eye Disease
Keratoconjunctivitis Sicca
Additional conditions recognized in this trial
Eye Diseases
Keratoconjunctivitis
More general conditions related to this trial
Conjunctival Diseases
Conjunctivitis
Corneal Diseases
Dry Eye Syndromes
Keratitis
Lacrimal Apparatus Diseases
Interventions listed in this trial
Lotemax
Restasis
Additional drug interventions recognized in this trial
Cyclosporine
Cyclosporins
Loteprednol etabonate
More general drug interventions related to this trial
Anti-Allergic Agents
Anti-Infective Agents
Antifungal Agents
Antirheumatic Agents
Dermatologic Agents
Enzyme Inhibitors
Immunologic Factors
Immunosuppressive Agents
Molecular Mechanisms of Pharmacological Action
Pharmacologic Actions
Physiological Effects of Drugs
Therapeutic Uses
Sponsors listed in this trial
Ophthalmic Consultants of Long Island
Bausch &Lomb, Inc.


Contact Help Desk
Lister Hill National Center for Biomedical Communications,  U.S. National Library of Medicine,
U.S. National Institutes of Health,  U.S. Department of Health & Human Services,
USA.gov,  Copyright,  Privacy,  Accessibility,  Freedom of Information Act

U.S. National Institutes of Health U.S. National Library of Medicine U.S. Department of Health & Human Services